Vaishali Pharma Limited (NSE:VAISHALI)
India · Delayed Price · Currency is INR 12.70
+0.36 (2.92%)
Aug 1, 2025, 3:29 PM IST
Vaishali Pharma Market Cap
Vaishali Pharma has a market cap or net worth of 1.54 billion as of August 1, 2025. Its market cap has decreased by -8.66% in one year.
Market Cap
1.54B
Enterprise Value
1.64B
Revenue
990.26M
Ranking
n/a
PE Ratio
210.42
Stock Price
12.70
Market Cap Chart
Since October 11, 2017, Vaishali Pharma's market cap has increased from 286.62M to 1.54B, an increase of 435.90%. That is a compound annual growth rate of 23.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 1.54B | -27.39% |
| Dec 31, 2024 | 2.12B | 9.71% |
| Dec 29, 2023 | 1.93B | 31.85% |
| Dec 30, 2022 | 1.46B | 286.75% |
| Dec 31, 2021 | 378.08M | -48.82% |
| Dec 31, 2020 | 738.76M | 115.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,159.97B |
| Divi's Laboratories | 1,765.37B |
| Cipla | 1,255.73B |
| Apollo Hospitals Enterprise | 1,071.20B |
| Mankind Pharma | 1,062.98B |
| Zydus Lifesciences | 975.85B |
| Aurobindo Pharma | 672.57B |
| Fortis Healthcare | 636.20B |